US Stock MarketDetailed Quotes

NVS Novartis AG

Watchlist
  • 97.700
  • +0.060+0.06%
Close Jan 6 16:00 ET
  • 97.700
  • 0.0000.00%
Post 20:01 ET
195.33BMarket Cap11.47P/E (TTM)

Novartis AG Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
18.51%6.29B
38.61%4.88B
-20.58%2.27B
9.06%14.22B
-32.40%2.55B
24.07%5.3B
-5.58%3.52B
72.95%2.85B
-2.44%13.04B
73.00%3.77B
Net income from continuing operations
110.51%3.19B
42.93%3.25B
25.02%2.69B
41.71%8.57B
100.61%2.64B
13.76%1.51B
33.98%2.27B
-3.11%2.15B
-73.59%6.05B
-91.34%1.32B
Operating gains losses
-156.45%-159M
-15.91%74M
132.89%99M
43.77%-167M
186.29%107M
-520.00%-62M
161.11%88M
-296.05%-301M
98.14%-297M
99.15%-124M
Depreciation and amortization
-36.84%1.97B
-31.97%1.16B
-29.73%1.31B
23.45%8.28B
-12.84%1.59B
62.45%3.11B
-5.22%1.71B
33.10%1.87B
19.80%6.71B
81.66%1.82B
Deferred tax
412.82%200M
47.64%595M
19.19%441M
-51.15%551M
-202.76%-261M
-84.82%39M
16.14%403M
-17.78%370M
-30.58%1.13B
68.21%254M
Other non cash items
182.00%41M
-71.54%-223M
65.18%-180M
-26,066.67%-785M
53.23%-87M
-134.01%-50M
-402.33%-130M
-10,240.00%-517M
98.56%-3M
-745.45%-186M
Change In working capital
-11.71%1.04B
332.73%238M
-63.30%-1.99B
53.64%-369M
-184.21%-384M
163.53%1.18B
201.85%55M
39.43%-1.22B
-990.41%-796M
-47.10%456M
-Change in receivables
380.34%328M
-12.08%-501M
-31.43%-920M
-278.84%-1.5B
-156.07%-240M
13.97%-117M
-8.23%-447M
-41.13%-700M
-12.78%-397M
100.94%428M
-Change in inventory
372.73%90M
90.27%-18M
64.54%-128M
2.50%-546M
171.74%33M
74.42%-33M
4.64%-185M
15.06%-361M
-449.02%-560M
-155.56%-46M
-Change in payables and accrued expense
40.76%-109M
-294.52%-142M
-1,673.08%-409M
364.64%479M
291.67%564M
-52.07%-184M
563.64%73M
118.18%26M
-63.06%-181M
-68.83%144M
-Change in other current assets
-425.00%-52M
-1,266.67%-105M
-149.54%-272M
-48.81%-125M
-2,150.00%-41M
-87.40%16M
-87.14%9M
69.97%-109M
53.07%-84M
-99.27%2M
-Change in other current liabilities
-47.66%783M
65.95%1B
-251.35%-260M
211.50%1.33B
-872.22%-700M
111.90%1.5B
28.18%605M
87.33%-74M
-36.51%426M
-4.35%-72M
Cash from discontinued investing activities
-80.12%238M
0
-83.41%74M
59M
105M
-29.84%1.2B
343M
Operating cash flow
16.88%6.29B
36.33%4.88B
-23.40%2.27B
1.56%14.46B
-38.04%2.55B
13.92%5.38B
-4.77%3.58B
79.32%2.96B
-5.54%14.24B
5.84%4.11B
Investing cash flow
Cash flow from continuing investing activities
81.34%-374M
-234.06%-3.21B
-108.40%-899M
252.89%6.72B
22.52%-1.02B
-137.75%-2B
91.74%-960M
14.31%10.71B
-61.12%1.9B
-125.11%-1.32B
Net PPE purchase and sale
-52.38%-320M
-0.90%-223M
-50.67%-226M
-8.58%-823M
-18.63%-242M
-4.48%-210M
9.43%-221M
33.04%-150M
11.35%-758M
-98.06%-204M
Net intangibles purchase and sale
-132.48%-455M
33.43%-448M
-920.88%-929M
122.72%262M
-95.31%-375M
664.92%1.4B
-238.19%-673M
83.02%-91M
-43.41%-1.15B
51.02%-192M
Net business purchase and sale
98.17%-63M
-3,773.26%-3.33B
-911.54%-263M
-313.08%-3.57B
-22.22%-11M
-57,533.33%-3.45B
-40.98%-86M
96.90%-26M
-104.22%-864M
-100.04%-9M
Net investment purchase and sale
84.46%463M
3,875.00%795M
-95.27%519M
131.82%10.85B
56.89%-394M
-95.64%251M
100.18%20M
0.07%10.97B
133.78%4.68B
93.88%-914M
Net other investing changes
--1M
----
----
----
----
----
----
----
98.18%-1M
--0
Cash from discontinued investing activities
Investing cash flow
83.09%-374M
-204.56%-3.21B
-108.46%-899M
281.20%5.6B
-19.97%-1.76B
-142.55%-2.21B
90.94%-1.05B
13.41%10.62B
-65.11%1.47B
-132.15%-1.47B
Financing cash flow
Cash flow from continuing financing activities
91.13%-382M
15.03%-3.2B
42.60%-5.16B
15.07%-17.56B
87.90%-496M
9.33%-4.31B
-63.60%-3.77B
5.58%-9B
-26.96%-20.68B
-25.08%-4.1B
Net issuance payments of debt
192.83%2.51B
207.62%833M
23.58%1.15B
25.15%-1.94B
148.41%610M
-31.07%-2.7B
-333.84%-774M
130.94%933M
56.82%-2.59B
59.50%-1.26B
Net common stock issuance
-75.63%-2.85B
45.35%-1.62B
61.92%-1.1B
18.15%-8.72B
53.29%-1.25B
40.21%-1.63B
-8.95%-2.96B
-13.53%-2.89B
-248.45%-10.65B
-1,709.46%-2.68B
Cash dividends paid
----
---2.42B
28.23%-5.21B
3.34%-7.26B
--0
----
----
3.34%-7.26B
-1.87%-7.51B
--0
Proceeds from stock option exercised by employees
--5M
--25M
----
53.00%153M
---5M
----
----
69.15%159M
88.68%100M
--0
Net other financing activities
-286.96%-43M
28.57%-25M
-120.75%-11M
605.26%192M
193.17%150M
-28.13%23M
-146.67%-35M
140.91%53M
-155.07%-38M
-794.44%-161M
Cash from discontinued financing activities
2,661.34%3.29B
-205.71%-111M
31,481.82%3.47B
129M
-206M
357.69%119M
105M
Financing cash flow
54.09%-382M
12.02%-3.2B
43.88%-5.16B
30.56%-14.28B
84.80%-607M
82.44%-832M
-57.99%-3.64B
3.42%-9.2B
-26.43%-20.56B
-22.85%-3.99B
Net cash flow
Beginning cash position
-27.40%7.9B
-21.09%9.47B
78.17%13.39B
-39.41%7.52B
42.16%12.41B
200.28%10.89B
-13.37%12B
-39.41%7.52B
28.46%12.41B
21.01%8.73B
Current changes in cash
228.00%5.53B
-37.52%-1.53B
-186.79%-3.8B
218.90%5.78B
161.33%828M
-67.46%1.69B
89.05%-1.11B
194.48%4.38B
-261.13%-4.86B
-125.98%-1.35B
Effect of exchange rate changes
206.02%176M
-3,300.00%-34M
-217.76%-126M
412.50%100M
13.48%160M
-107.50%-166M
98.08%-1M
360.98%107M
87.97%-32M
--141M
End cash Position
9.71%13.61B
-27.40%7.9B
-21.09%9.47B
78.17%13.39B
78.17%13.39B
42.16%12.41B
200.28%10.89B
-13.37%12B
-39.41%7.52B
-39.41%7.52B
Free cash flow
16.87%5.49B
54.85%4.15B
-56.81%1.11B
-2.43%11.71B
-51.18%1.76B
10.50%4.7B
-15.57%2.68B
225.06%2.57B
-4.14%12B
8.76%3.61B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 18.51%6.29B 38.61%4.88B -20.58%2.27B 9.06%14.22B -32.40%2.55B 24.07%5.3B -5.58%3.52B 72.95%2.85B -2.44%13.04B 73.00%3.77B
Net income from continuing operations 110.51%3.19B 42.93%3.25B 25.02%2.69B 41.71%8.57B 100.61%2.64B 13.76%1.51B 33.98%2.27B -3.11%2.15B -73.59%6.05B -91.34%1.32B
Operating gains losses -156.45%-159M -15.91%74M 132.89%99M 43.77%-167M 186.29%107M -520.00%-62M 161.11%88M -296.05%-301M 98.14%-297M 99.15%-124M
Depreciation and amortization -36.84%1.97B -31.97%1.16B -29.73%1.31B 23.45%8.28B -12.84%1.59B 62.45%3.11B -5.22%1.71B 33.10%1.87B 19.80%6.71B 81.66%1.82B
Deferred tax 412.82%200M 47.64%595M 19.19%441M -51.15%551M -202.76%-261M -84.82%39M 16.14%403M -17.78%370M -30.58%1.13B 68.21%254M
Other non cash items 182.00%41M -71.54%-223M 65.18%-180M -26,066.67%-785M 53.23%-87M -134.01%-50M -402.33%-130M -10,240.00%-517M 98.56%-3M -745.45%-186M
Change In working capital -11.71%1.04B 332.73%238M -63.30%-1.99B 53.64%-369M -184.21%-384M 163.53%1.18B 201.85%55M 39.43%-1.22B -990.41%-796M -47.10%456M
-Change in receivables 380.34%328M -12.08%-501M -31.43%-920M -278.84%-1.5B -156.07%-240M 13.97%-117M -8.23%-447M -41.13%-700M -12.78%-397M 100.94%428M
-Change in inventory 372.73%90M 90.27%-18M 64.54%-128M 2.50%-546M 171.74%33M 74.42%-33M 4.64%-185M 15.06%-361M -449.02%-560M -155.56%-46M
-Change in payables and accrued expense 40.76%-109M -294.52%-142M -1,673.08%-409M 364.64%479M 291.67%564M -52.07%-184M 563.64%73M 118.18%26M -63.06%-181M -68.83%144M
-Change in other current assets -425.00%-52M -1,266.67%-105M -149.54%-272M -48.81%-125M -2,150.00%-41M -87.40%16M -87.14%9M 69.97%-109M 53.07%-84M -99.27%2M
-Change in other current liabilities -47.66%783M 65.95%1B -251.35%-260M 211.50%1.33B -872.22%-700M 111.90%1.5B 28.18%605M 87.33%-74M -36.51%426M -4.35%-72M
Cash from discontinued investing activities -80.12%238M 0 -83.41%74M 59M 105M -29.84%1.2B 343M
Operating cash flow 16.88%6.29B 36.33%4.88B -23.40%2.27B 1.56%14.46B -38.04%2.55B 13.92%5.38B -4.77%3.58B 79.32%2.96B -5.54%14.24B 5.84%4.11B
Investing cash flow
Cash flow from continuing investing activities 81.34%-374M -234.06%-3.21B -108.40%-899M 252.89%6.72B 22.52%-1.02B -137.75%-2B 91.74%-960M 14.31%10.71B -61.12%1.9B -125.11%-1.32B
Net PPE purchase and sale -52.38%-320M -0.90%-223M -50.67%-226M -8.58%-823M -18.63%-242M -4.48%-210M 9.43%-221M 33.04%-150M 11.35%-758M -98.06%-204M
Net intangibles purchase and sale -132.48%-455M 33.43%-448M -920.88%-929M 122.72%262M -95.31%-375M 664.92%1.4B -238.19%-673M 83.02%-91M -43.41%-1.15B 51.02%-192M
Net business purchase and sale 98.17%-63M -3,773.26%-3.33B -911.54%-263M -313.08%-3.57B -22.22%-11M -57,533.33%-3.45B -40.98%-86M 96.90%-26M -104.22%-864M -100.04%-9M
Net investment purchase and sale 84.46%463M 3,875.00%795M -95.27%519M 131.82%10.85B 56.89%-394M -95.64%251M 100.18%20M 0.07%10.97B 133.78%4.68B 93.88%-914M
Net other investing changes --1M ---- ---- ---- ---- ---- ---- ---- 98.18%-1M --0
Cash from discontinued investing activities
Investing cash flow 83.09%-374M -204.56%-3.21B -108.46%-899M 281.20%5.6B -19.97%-1.76B -142.55%-2.21B 90.94%-1.05B 13.41%10.62B -65.11%1.47B -132.15%-1.47B
Financing cash flow
Cash flow from continuing financing activities 91.13%-382M 15.03%-3.2B 42.60%-5.16B 15.07%-17.56B 87.90%-496M 9.33%-4.31B -63.60%-3.77B 5.58%-9B -26.96%-20.68B -25.08%-4.1B
Net issuance payments of debt 192.83%2.51B 207.62%833M 23.58%1.15B 25.15%-1.94B 148.41%610M -31.07%-2.7B -333.84%-774M 130.94%933M 56.82%-2.59B 59.50%-1.26B
Net common stock issuance -75.63%-2.85B 45.35%-1.62B 61.92%-1.1B 18.15%-8.72B 53.29%-1.25B 40.21%-1.63B -8.95%-2.96B -13.53%-2.89B -248.45%-10.65B -1,709.46%-2.68B
Cash dividends paid ---- ---2.42B 28.23%-5.21B 3.34%-7.26B --0 ---- ---- 3.34%-7.26B -1.87%-7.51B --0
Proceeds from stock option exercised by employees --5M --25M ---- 53.00%153M ---5M ---- ---- 69.15%159M 88.68%100M --0
Net other financing activities -286.96%-43M 28.57%-25M -120.75%-11M 605.26%192M 193.17%150M -28.13%23M -146.67%-35M 140.91%53M -155.07%-38M -794.44%-161M
Cash from discontinued financing activities 2,661.34%3.29B -205.71%-111M 31,481.82%3.47B 129M -206M 357.69%119M 105M
Financing cash flow 54.09%-382M 12.02%-3.2B 43.88%-5.16B 30.56%-14.28B 84.80%-607M 82.44%-832M -57.99%-3.64B 3.42%-9.2B -26.43%-20.56B -22.85%-3.99B
Net cash flow
Beginning cash position -27.40%7.9B -21.09%9.47B 78.17%13.39B -39.41%7.52B 42.16%12.41B 200.28%10.89B -13.37%12B -39.41%7.52B 28.46%12.41B 21.01%8.73B
Current changes in cash 228.00%5.53B -37.52%-1.53B -186.79%-3.8B 218.90%5.78B 161.33%828M -67.46%1.69B 89.05%-1.11B 194.48%4.38B -261.13%-4.86B -125.98%-1.35B
Effect of exchange rate changes 206.02%176M -3,300.00%-34M -217.76%-126M 412.50%100M 13.48%160M -107.50%-166M 98.08%-1M 360.98%107M 87.97%-32M --141M
End cash Position 9.71%13.61B -27.40%7.9B -21.09%9.47B 78.17%13.39B 78.17%13.39B 42.16%12.41B 200.28%10.89B -13.37%12B -39.41%7.52B -39.41%7.52B
Free cash flow 16.87%5.49B 54.85%4.15B -56.81%1.11B -2.43%11.71B -51.18%1.76B 10.50%4.7B -15.57%2.68B 225.06%2.57B -4.14%12B 8.76%3.61B
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion --
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Cancer Research
Cancer Research
Intraday+0.42%
CAR-T Therapy
CAR-T Therapy
Intraday+0.03%